The price of prescription medications continues to shape healthcare decisions for families across Oregon, where many residents rely on daily medications to manage chronic illnesses, maintain their quality of life, and avoid more serious medical complications. While advances in medicine have expanded treatment options for conditions ranging from diabetes and heart disease to kidney disorders and autoimmune illnesses, the financial burden of obtaining those medications remains a growing concern for patients, healthcare providers, and policymakers alike.
A newly released analysis by the AARP Public Policy Institute has added fresh data to a discussion that has been unfolding for years. The report found that the prices of 25 of the nation’s best-selling brand-name prescription drugs increased an average of 81 percent after reaching the U.S. market. During the same period, prices for those same medications fell an average of 13 percent across 19 other developed countries, illustrating a widening gap between what Americans pay for many prescription drugs and what patients in comparable nations are charged.
For Southern Oregon residents, where many communities have substantial populations of retirees, veterans, and individuals living with long-term medical conditions, prescription affordability has become more than an economic issue. It is increasingly viewed as a public health concern because consistent access to medication often determines whether chronic diseases remain under control or progress into more serious and costly medical problems.
Several factors contribute to the higher prices seen in the United States. Unlike many countries that negotiate medication prices through national healthcare systems, the American pharmaceutical market has historically relied on a combination of private insurers, pharmacy benefit managers, manufacturers, and government programs operating under different pricing structures. That complex system often results in patients paying significantly different amounts for the same medication depending on their insurance coverage, eligibility for assistance programs, or pharmacy benefits.
Recent federal reforms have begun changing portions of that system. Medicare now has authority to negotiate prices for selected high-cost prescription medications, and annual out-of-pocket prescription expenses for many Medicare beneficiaries have been capped. Healthcare analysts view those changes as meaningful progress for eligible seniors, although many prescription drugs remain outside those negotiations, and the reforms do not extend equally to every patient covered through private insurance or other health plans.
Oregon has also taken steps to examine prescription affordability through the state’s Prescription Drug Affordability Board. The independent board evaluates whether certain medications create significant financial challenges for consumers and continues gathering public feedback to better understand how rising prescription costs affect households throughout the state. That information may help guide future policy recommendations intended to improve affordability while maintaining access to necessary treatments.
The latest national analysis echoes concerns already familiar to many Oregon families.
“Oregonians should not be paying more for the same medications that cost less in other countries,” said Bandana Shrestha, Oregon State Director for AARP. “This report reinforces what we hear every day from people across our state — the cost of prescription drugs is simply too high, and too many are forced to make impossible choices between their health and basic needs. While progress like Medicare drug price negotiation is helping, more work is needed to ensure that all Oregonians can afford their medications.”
The financial impact often becomes most visible among households managing multiple chronic conditions. Medications prescribed to treat diabetes, cardiovascular disease, kidney disease, respiratory illnesses, arthritis, and other long-term conditions may be required indefinitely, leaving patients vulnerable to repeated price increases over time. Even individuals with health insurance can face substantial deductibles, copayments, coinsurance obligations, or coverage limitations that increase annual healthcare expenses.
Lee Bliven, an Oregon resident whose family faces significant prescription costs, described the reality many households continue to experience.
“My wife and I are both retired and disabled, and her medications alone cost thousands each month,” Bliven said. “We’re fortunate to have support right now — but even with that help, it’s a constant struggle to keep up. Too many Oregonians are one step away from having to choose between their health and their home.”
Medical professionals have long recognized that delaying or skipping prescribed medications because of cost can increase the likelihood of emergency medical treatment, hospital admissions, and worsening chronic illness. Maintaining access to prescribed therapies remains one of the most effective ways to prevent avoidable complications and improve long-term health outcomes.
As healthcare costs continue evolving, prescription affordability is expected to remain an important issue throughout Oregon. Ongoing federal reforms, state-level reviews, and continued examination of pharmaceutical pricing practices will likely shape future discussions about balancing medical innovation with affordable access. For thousands of Southern Oregon residents who depend on prescription medications every day, the outcome of those efforts may influence not only household finances, but also long-term health and quality of life.